Overview

Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer

Status:
Terminated

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether sorafenib in combination with chemotherapy has a positive effect on time to progression of the tumor or death for the treatment of large bowel cancer that has already progressed during a first chemotherapy.

Phase:

Phase 2

Details

Lead Sponsor:

AIO-Studien-gGmbH

Treatments:

Fluorouracil
Irinotecan
Leucovorin
Niacinamide
Oxaliplatin
Sorafenib